Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
10.78 USD | +2.76% | -6.83% | -12.00% |
Kurzporträt
Mitarbeiterzahl: 118
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 26.03.04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01.08.16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 03.05.21 |
Ryan Baker
IRC | Investor Relations Contact | - | 01.05.23 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 25.07.23 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 01.11.16 |
Mike Smith
PRN | Corporate Officer/Principal | - | 01.02.16 |
Rachel Morten
LAW | General Counsel | - | 01.01.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 01.02.19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01.08.16 |
Albert Cha
BRD | Director/Board Member | 51 | 01.01.16 |
Edward Unkart
BRD | Director/Board Member | 74 | 01.12.14 |
Nancy Stuart
BRD | Director/Board Member | 65 | 18.03.21 |
Patrick Treanor
BRD | Director/Board Member | - | 26.05.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 42 188 296 | 41 706 792 ( 98,86 %) | 0 | 98,86 % |
Unternehmenskontakt
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-12.00% | 455 Mio. | |
-4.66% | 86.13 Mrd. | |
+1.32% | 39.82 Mrd. | |
-19.27% | 30.42 Mrd. | |
+57.86% | 25.23 Mrd. | |
-16.09% | 15.36 Mrd. | |
-9.14% | 11.95 Mrd. | |
-17.69% | 11.6 Mrd. | |
-43.00% | 11.51 Mrd. | |
+5.24% | 8.71 Mrd. |
- Börse
- Aktien
- A2DG49 Aktie
- Unternehmen KalVista Pharmaceuticals, Inc.